Abbott Laboratories confirms Justice Department probe following infant formula crisis
Trouble continues for Abbott Laboratories, which shut down an infant formula plant last year amid reported illnesses.
Jan 23, 2023
0
2
Trouble continues for Abbott Laboratories, which shut down an infant formula plant last year amid reported illnesses.
Jan 23, 2023
0
2
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
The investigational drug vupanorsen reduced total levels of non-high-density lipoprotein (non-HDL) cholesterol by up to 28% in patients with high cholesterol who were already taking a cholesterol-lowering statin medication, ...
Apr 4, 2022
0
13
(HealthDay)—Two major U.S. health systems say they will not administer the controversial new Alzheimer's drug Aduhelm.
Jul 15, 2021
0
1
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or ...
May 17, 2021
0
10
Montefiore Health System and Albert Einstein College of Medicine are the first sites in the nation to begin evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19 ...
May 25, 2020
0
75
Why develop new drugs to combat the replication of the coronavirus if existing approved substances could do the same thing? Repurposing drugs in this fashion could offer a faster remedy against pathogens that have as yet ...
Apr 10, 2020
0
0
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor ...
Feb 26, 2020
0
1
More than 14 million Americans suffer from clinical depression, yet one in three doesn't experience relief from approved antidepressant drugs. A new treatment approach involving drugs called neurosteroids is on the horizon, ...
Nov 1, 2019
1
161
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European ...
Jun 19, 2019
0
0